Avalo Therapeutics Ord shares owned by UBS Group
Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Avalo Therapeutics Ord
Tip: Access up to 7 years of quarterly data
All positions including Avalo Therapeutics Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Avalo Therapeutics Ord by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $18 | 2 | 9.00 |